Augustin, M.; Wegtowska, J.; Lebwohl, M.; Paul, C.; Piguet, V.; Sofen, H.; Blauvelt, A.; Peterson, L.; al., E. Durability of Response in Patients With Chronic Plaque Psoriasis Treated With Certolizumab Pegol over 48 Weeks: Pooled Results from Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT). J of Skin 2018, 2, S87.